Panoramic Presentation and Tolerance Mechanism of Human Endometrium Based on Tiangui Theory

Launched by HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE · Apr 23, 2021

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion criteria:
• • 1. The subject's infertility factors are only male factors and/or fallopian tube factors;
• • 2. Age: 21/28/35/42/49 years old (calculated according to the birthday month of the Gregorian calendar, no more than 6 months before and after);
• • 3. Body mass index (weight/height square)=23～25kg/m2;
• • 4. The menstrual cycle is 28+/-1 days (that is, the menstruation is 2-3 days in advance of each month), and the consistency of the past 6 consecutive months (not more than 1 day before and after, that is, 27-29 days);
• • 5. Women with a history of pregnancy are preferred;
• • 6. Asexual life during the study period;
• • 7. No IUD is placed in the uterine cavity;
• • 8. Volunteer to participate in the experiment and sign the informed consent form.
• Exclusion criteria:
• • 1. Women who have a history of miscarriage;
• • 2. Women during pregnancy and breastfeeding;
• • 3. Mentally ill;
• • 4. Those who have had oral contraceptives or hormonal drugs in the past three months;
• • 5. Combined with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system;
• • 6. Subjects who have participated in other drug clinical trials within six months;
• • 7. Those who have poor compliance and the investigator thinks it is inappropriate to participate in this clinical trial.